Zonisamide: Chemistry, mechanism of action, and pharmacokinetics

Seizure

Volumn 13, Issue SUPPL. 1, 2004, Pages

  Leppik, Ilo E ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Chemistry; Epilepsy; Mechanism of action; Pharmacokinetics; Zonisamide

Indexed keywords

4 AMINOBUTYRIC ACID; ACETAZOLAMIDE; CALCIUM CHANNEL L TYPE; CALCIUM CHANNEL T TYPE; CARBAMAZEPINE; CARBAMAZEPINE 10,11 OXIDE; CARBONATE DEHYDRATASE; CLONAZEPAM; CYTOCHROME P450; GLUTAMIC ACID; HYDROXYL RADICAL; LIVER ENZYME; NITRIC OXIDE; PHENOBARBITAL; PHENYTOIN; SODIUM CHANNEL; VALPROIC ACID; ZONISAMIDE;

ANTICONVULSANT ACTIVITY; ARTICLE; CLINICAL TRIAL; CONCENTRATION RESPONSE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG EFFICACY; DRUG MEGADOSE; DRUG METABOLISM; DRUG STRUCTURE; ENZYME INHIBITION; FOCAL EPILEPSY; HUMAN; NERVE CELL; NONHUMAN; PLASMA PROTEIN BINDING; PRIORITY JOURNAL; SEIZURE; TITRIMETRY; TONIC CLONIC SEIZURE;

ANIMALS; ANTICONVULSANTS; AREA UNDER CURVE; CYTOCHROME P-450 ENZYME SYSTEM; DRUG INTERACTIONS; HUMANS; HYDROXYL RADICAL; ISOXAZOLES; NITRIC OXIDE;

EID: 7044271164     PISSN: 10591311     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.seizure.2004.04.016     Document Type: Article

References (12)

1. Leppik I. Willmore L. Homan R. et al. Efficacy and safety of zonisamide: Results of a multicenter study Epilepsy Res. 14 1993 165-173
2. Seino, M, Naruto, S, Ito, T, Miyazaki, H. Zonisamide. In: Levy, RH, Mattson, RH, Meldrum, BS, editors. Antiepileptic Drugs. New York: Raven Press Ltd.; 1995. 1011-23.
3. Masuda Y. Karasawa T. Shiraishi Y. Hori M. Yoshida K. Shimizu M. 3-Sulfamoylmethyl-1,2-benzisoxazole, a new type of anticonvulsant drug: Pharmacological profile Arzneimittel-Forschung 30 1980 477-483
4. Ito T. Hori M. Masuda Y. Yoshida K. Shimizu M. 3-Sulfamoylmethyl-1,2-benzisoxazole, a new type of anticonvulsant drug: Electroencephalographic profile Arzneimittel-Forschung 30 1980 603-609
5. Wada Y. Hasegawa H. Okuda H. Yamaguchi N. Anticonvulsant effects of zonisamide and phenytoin on seizure activity of the feline visual cortex Brain Dev. 12 1990 206-210
6. Eisai Inc. Data on file, 1999.
7. Mori A. Noda Y. Packer L. The anticonvulsant zonisamide scavenges free radicals Epilepsy Res. 30 1998 153-158
8. Kochak G. Page J. Buchanan R. Peters R. Padgett C. Steady-state pharmacokinetics of zonisamide, an antiepileptic agent for treatment of refractory complex partial seizures J. Clin. Pharmacol. 38 1998 166-171
9. Stiff D.D. Robicheau J.T. Zemaitis M.A. Reductive metabolism of the anticonvulsant agent zonisamide, a 1,2-benzisoxazole derivative Xenobiotica 22 1992 1-11
10. Nakasa H. Ohmori S. Kitada M. Formation of 2-sulphamoylacetylphenol from zonisamide under aerobic conditions in rat liver microsomes Xenobiotica 26 1996 495-501
11. Ojemann L. Shastri R. Wilensky A. et al. Comparative pharmacokinetics of zonisamide (CI-912) in epileptic patients on carbamazepine or phenytoin monotherapy Ther. Drug Monit. 8 1986 293-296
12. Shinoda M. Akita M. Hasegawa M. Hasegawa T. Nabeshima T. The necessity of adjusting the dosage of zonisamide when coadministered with other anti-epileptic drugs Biol. Pharm. Bull. 19 1996 1090-1092